Ali Sharafi
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
Papers in
-
- Plant tissue culture and regeneration 25
- Natural product bioactivities and synthesis 12
-
- Phytochemistry and Biological Activities 18
- Co-authors
- Hossein Danafar (47 shared papers)Hamidreza Kheiri Manjili (12 shared papers)Mahmoud Gharbavi (16 shared papers)Hamed Nosrati (9 shared papers)Jafar Amani (3 shared papers)Haleh Hashemi Sohi (10 shared papers)Zahra Gharari (20 shared papers)Bahman Hosseini (2 shared papers)
- Journals
- Scientific Reports (4 papers)Physiology and Molecular Biology of Plants (4 papers)Physics in Medicine and Biology (3 papers)Toxicon (3 papers)Heliyon (3 papers)
- Partner nations
- IranTürkiyeUnited Kingdom
In The Last Decade
Ali Sharafi
137 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 132
- Biomaterials 671
- Molecular Medicine 211
- Pharmaceutical Science 259
- Biotechnology 227
- Molecular Biology 1.2k
Countries citing papers authored by Ali Sharafi
This map shows the geographic impact of Ali Sharafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Sharafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Sharafi more than expected).
Fields of papers citing papers by Ali Sharafi
This network shows the impact of papers produced by Ali Sharafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Sharafi. The network helps show where Ali Sharafi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Sharafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 244 | |
| 2 | 2018 | 235 | |
| 3 | 2017 | 119 | |
| 4 | 2021 | 115 | |
| 5 | 2016 | 105 | |
| 6 | 2018 | 75 | |
| 7 | 2018 | 73 | |
| 8 | 2021 | 64 | |
| 9 | 2020 | 63 | |
| 10 | 2020 | 57 | |
| 11 | 2016 | 53 | |
| 12 | 2012 | 51 | |
| 13 | 2018 | 51 | |
| 14 | 2012 | 49 | |
| 15 | 1979 | 49 | |
| 16 | 2017 | 48 | |
| 17 | 2014 | 48 | |
| 18 | 2017 | 47 | |
| 19 | 2019 | 46 | |
| 20 | 2013 | 41 |
About Ali Sharafi
Ali Sharafi is a scholar working on Molecular Biology, Plant Science, Pharmacology, Biomaterials and Biomedical Engineering, having authored 144 papers that have together received 2.9k indexed citations. Recurring topics across this work include Plant tissue culture and regeneration (25 papers), Flavonoids in Medical Research (20 papers), Nanoparticle-Based Drug Delivery (20 papers), Phytochemistry and Biological Activities (18 papers), Natural product bioactivities and synthesis (12 papers), Transgenic Plants and Applications (11 papers), Nanoplatforms for cancer theranostics (11 papers) and Curcumin's Biomedical Applications (10 papers). The work is most often cited by research in Biomaterials (671 citations), Molecular Medicine (211 citations), Pharmaceutical Science (259 citations), Biotechnology (227 citations) and Molecular Biology (1.2k citations). Ali Sharafi has collaborated with scholars based in Iran, Türkiye and United Kingdom. Frequent co-authors include Hossein Danafar, Hamidreza Kheiri Manjili, Mahmoud Gharbavi, Hamed Nosrati, Jafar Amani, Haleh Hashemi Sohi, Zahra Gharari, Bahman Hosseini, Pejman Azadi and Mozhgan Aghajanzadeh. Their work appears in journals such as Scientific Reports, Physiology and Molecular Biology of Plants, Physics in Medicine and Biology, Toxicon and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.